BMDCs that were pretreated with LFM-A13 and then stimulated with the indicated NLRP3 inflammasome activators for 3 h. (e) ELISA of human IL-1β in supernatants of THP-1-Mfs that were pretreated with LFM-A13 or R406 and then stimulated with poly(dA:dT) for 3 h. (f) Immunoblot analysis of human IL-1β p17 and caspase-1 p20 in supernatants of LPS-primed human blood monocytes that were pretreated with LFM-A13 and then stimulated with the indicated inflammasome activators for 3 h. (g) ELISA of human IL-1β in supernatants of BTK-knockdown and control THP-1-Mfs stimulated without or with alum or poly(dA:dT) for 3 h. Data are representative of three independent experiments. Data are presented as mean ± SD (triplicate). *, P < 0.03; **, P < 0.01; ***, P < 0.003. 
